Carolyn McCoySenior Policy Analyst
Research institute · Research orgs · Washington, DC · Est. 2023
Blueprint Biosecurity is a U.S.-based 501(c)(3) nonprofit that focuses on pathogen-agnostic interventions intended to reduce the risk and severity of future biological threats and pandemics. The organization’s stated vision is to enable society to “detect, prevent, and stop disease outbreaks before they become pandemics,” and it pursues this by combining (1) evidence generation for promising countermeasures, (2) development of implementation pathways, and (3) policy-relevant engagement with government, academia, industry, and philanthropy.
Its current technical/programmatic portfolio is organized around personal protective equipment (PPE) and indoor transmission suppression approaches, including far-UVC, glycol vapors, and conventional germicidal ultraviolet (GUV). Blueprint also runs grant programs that fund research intended to answer safety, efficacy, and deployment questions for these interventions, and it publishes technical explainers and program updates through its “resources” and “news” sections.
No curated programs yet. Check the careers page ↗.
Publications are not yet indexed for this organization. Read them on blueprintbiosecurity.org ↗.
Blueprint Biosecurity posted a one-pager blog explaining conventional germicidal ultraviolet (GUV), including how upper-room systems work and key considerations for use and deployment.
Blueprint Biosecurity Enters into Partnership with U.S. Environmental Protection AgencyBlueprint Biosecurity announced a Collaborative Research and Development Agreement (CRADA) with the U.S. Environmental Protection Agency to evaluate air treatment interventions (including far-UVC and glycol vapors) using the EPA Aerosol Test Facility over the next two years.
Glycol Vapors Explained: What They Are and What We Know So FarBlueprint Biosecurity published a Q&A-style explainer describing what glycol vapors are and summarizing the current evidence, potential applications, and remaining questions, including safety and efficacy considerations.
Blueprint Biosecurity Announces FILTER Award RecipientsBlueprint Biosecurity announced more than $1.7M in grants under its Filtration Loss Testing in Respirator Equipment Research (FILTER) program to study respirator filter degradation under real-world and simulated conditions, led by two research groups.
How a Pandemic Shaped the Framework for Blueprint BiosecurityBlueprint Biosecurity published a retrospective explaining the organization’s founding and how it shaped its model for blueprints, coordinated research programs, and advocacy focused on pandemic preparedness and response.
Blueprint Biosecurity Announces GlycolISER Award RecipientsBlueprint Biosecurity announced approximately $4.5M in grants under its Glycol Vapors for Infection Suppression – Efficacy and Safety Research (GlycolISER) program across five technical areas focused on glycol vapor safety, efficacy, interactions with filtration media, human safety, and real-world field observations.